http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5700833-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae396ee5f0528a574a52aa6bc1700e37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2d42040a364d1fca0b2a7f9f9e8de9c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-54
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-732
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-54
filingDate 1996-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1997-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8781cfe566538350b49047bf36b099b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54ed71e45c0640ed222e5b01019fe4a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0e8814bc96d3251685f18e2a0a7aedf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_432aac2add76b23c291df9029c7f6148
publicationDate 1997-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5700833-A
titleOfInvention Isocarbacyclin derivatives
abstract The present invention provides novel isocarbacyclin derivatives useful for search and study of prostacyclin receptor and as a therapeutic drug for central nervous system diseases, which derivatives are expressed by the following formula I!: ##STR1## where, R 1 represents a hydrogen atom, an alkyl group, or cation of an appropriate amount, and R 2 an alkylene group.!
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009176848-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0911314-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9388154-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015025255-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6884819-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10149909-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006029735-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-775434-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9546145-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0110445-A1
priorityDate 1995-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4307112-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396372
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393647
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393308
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135867497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128445969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3007
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6435378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57057249
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87057611
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234220320
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399940
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226206
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226870908
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57417222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6436040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127979515
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395791
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87057777
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67680132

Total number of triples: 56.